DPP9 is a novel component of the N-end rule pathway targeting the Tyrosine Kinase Syk.

Daniela Justa-Schuch,Maria Silva-Garcia,Esther Pilla,Michael Engelke,Markus Kilisch,Christof Lenz,Ulrike Möller,Fumihiko Nakamura,Henning Urlaub,Ruth Geiss-Friedlander

DOI: https://doi.org/10.7554/elife.16370

IF: 7.7

2016-01-01

eLife

Abstract:The aminopeptidase DPP9 removes dipeptides from N-termini of substrates having a proline or alanine in second position. Although linked to several pathways including cell survival and metabolism, the molecular mechanisms underlying these outcomes are poorly understood. We identified a novel interaction of DPP9 with Filamin A, which recruits DPP9 to Syk, a central kinase in B-cell signalling. Syk signalling can be terminated by degradation, requiring the ubiquitin E3 ligase Cbl. We show that DPP9 cleaves Syk to produce a neo N-terminus with serine in position 1. Pulse chases combined with mutagenesis studies reveal that Seri strongly influences Syk stability. Furthermore, DPP9 silencing reduces Cbl interaction with Syk, suggesting that DPP9 processing is a prerequisite for Syk ubiquitination. Consistently, DPP9 inhibition stabilizes Syk, thereby modulating Syk signalling. Taken together, we demonstrate DPP9 as a negative regulator of Syk and conclude that DPP9 is a novel integral aminopeptidase of the N-end rule pathway.